Epilepsy tech company NeuroOne starts trading on the Nasdaq
The uplisting had been in the works since at least January, when NeuroOne raised $12.5 million through a private placement to undisclosed investors.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Carrigan Miller Source Type: news